BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31977467)

  • 1. 68Ga-Prostate-Specific Membrane Antigen Uptake in Cerebral Tuberculosis.
    Wong VCK; Shen L; Nasser E; Adams DN; Mansberg R
    Clin Nucl Med; 2020 Mar; 45(3):238-240. PubMed ID: 31977467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-Prostate-Specific Membrane Antigen Uptake in Dissecting Abdominal Aortic Aneurysm.
    Wong VCK; Yip JWL; Stevanovic A; Le K; Mansberg R
    Clin Nucl Med; 2020 Jun; 45(6):455-458. PubMed ID: 32149812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avid 68Ga-PSMA Uptake in Periappendicular Abscess.
    Christensen MT; Klingenberg S; Gormsen LC; Jochumsen MR; Bouchelouche K
    Clin Nucl Med; 2020 Nov; 45(11):929-930. PubMed ID: 32969906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous Paraganglioma Masquerading as 68Ga-PSMA PET/CT-Avid Metastasis in Carcinoma Prostate-How Specific Is 68Ga-PSMA PET/CT?
    Tyagi S; Singh SK; Narain TA; Singh H; Kumar R; Vadi SK
    Clin Nucl Med; 2019 Jun; 44(6):e420-e422. PubMed ID: 31021914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection Efficacy of Hybrid
    Einspieler I; Rauscher I; Düwel C; Krönke M; Rischpler C; Habl G; Dewes S; Ott A; Wester HJ; Schwaiger M; Maurer T; Eiber M
    J Nucl Med; 2017 Jul; 58(7):1081-1087. PubMed ID: 28209912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
    Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
    J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Change of 68Ga-Prostate-Specific Membrane Antigen Uptake in Myeloma After Chemotherapy in a Patient With Multiple Myeloma and Concurrent Prostate Cancer.
    Pan Q; Luo Y; Ma Y; Li F
    Clin Nucl Med; 2020 Dec; 45(12):1013-1015. PubMed ID: 33086276
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Hamed MAG; Basha MAA; Ahmed H; Obaya AA; Afifi AHM; Abdelbary EH
    Acad Radiol; 2019 Apr; 26(4):450-460. PubMed ID: 29935970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68Ga-PMSA Uptake in the Lung: Metastatic Versus Primary Lung Tumor.
    Usmani S; Sadeq A; Marafi F; Esmail A; Al Kandari F; Ahmed N
    Clin Nucl Med; 2020 Feb; 45(2):e80-e82. PubMed ID: 31876815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-Prostate-Specific Membrane Antigen Uptake in a Pancreatic Neuroendocrine Tumor.
    Luong TV; Iversen P; Bouchelouche K; Arveschoug AK
    Clin Nucl Med; 2020 May; 45(5):379-382. PubMed ID: 32149792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental Detection of Pleomorphic Sarcoma on 68Ga-PSMA PET/CT in a Patient With Prostate Cancer.
    Mathew B; Agrawal A; Purandare NC; Ramadwar M; Menon S; Bakshi G; Joshi A; Puranik A; Shah S; Rangarajan V
    Clin Nucl Med; 2020 Feb; 45(2):e120-e121. PubMed ID: 31490315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early dynamic imaging in
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; Warwitz B; Scarpa L; Roig LG; Kendler D; von Guggenberg E; Bektic J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):765-775. PubMed ID: 27900519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [
    Berliner C; Tienken M; Frenzel T; Kobayashi Y; Helberg A; Kirchner U; Klutmann S; Beyersdorff D; Budäus L; Wester HJ; Mester J; Bannas P
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):670-677. PubMed ID: 27896369
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schwannoma Showing Avid Uptake on 68Ga-PSMA-HBED-CC PET/CT.
    Kanthan GL; Izard MA; Emmett L; Hsiao E; Schembri GP
    Clin Nucl Med; 2016 Sep; 41(9):703-4. PubMed ID: 27405039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.
    Verburg FA; Pfister D; Heidenreich A; Vogg A; Drude NI; Vöö S; Mottaghy FM; Behrendt FF
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):397-403. PubMed ID: 26563121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse Pulmonary Metastases From Prostate Cancer on 68Ga PSMA PET/CT.
    Seniaray N; Verma R; Belho E; Malik D; Mahajan H
    Clin Nucl Med; 2019 Nov; 44(11):898-900. PubMed ID: 31361647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.